Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

Publication files not online:

Author: Bos, R. · Nieuwenhuizen, W.
Type:article
Date:1992
Institution: Instituut voor Verouderings- en Vaatziekten Onderzoek TNO
Source:Annals of the New York Academy of Sciences, 667, 428-430
Identifier: 232010
doi: doi:/10.1111/j.1749-6632.1992.tb51644.x
Keywords: Health · fibrin · monoclonal antibody · plasminogen activator · tissue plasminogen activator · urokinase · drug carrier · cell fusion · conference paper · drug binding · drug efficacy · drug megadose · endothelium cell · enzyme activity · fibrinolysis · fibrinolytic therapy · hybridoma · plasminogen activation · antibody specificity · drug effect · immunology · metabolism · Antibodies, Monoclonal · Antibody Specificity · Drug Carriers · Fibrin · Fibrinolysis · Human · Kinetics · Plasminogen Activator Inhibitor 1 · Tissue Plasminogen Activator · Urinary Plasminogen Activator